Inhibrx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Receivables	0.3	0.78	0.26
Inventory	8.31	9.63	0.81
Prepaid Expenses	3.99	1.97	4.53
Other Current Assets	1.58	1.09	0.67
Total Current Assets	14.18	13.47	6.26
Property, Plant & Equipment	9.45	9.37	7.22
Other Long-Term Assets	4.59	3.16	3.16
Total Assets	28.22	26	16.65
Accounts Payable	17.54	12.87	9.45
Accrued Expenses	18.78	17.94	9.46
Current Portion of Leases	2.12	2.06	1.86
Total Current Liabilities	38.43	32.86	20.77
Long-Term Leases	0.56	1.11	3.17
Total Liabilities	38.99	33.97	23.95
Common Stock	-10.77	-7.97	-7.3
Shareholders' Equity	-10.77	-7.97	-7.3
Total Liabilities & Equity	28.22	26	16.65
Total Debt	2.68	3.17	5.03
Net Cash (Debt)	-2.68	-3.17	-5.03
Working Capital	-24.25	-19.4	-14.51
Tangible Book Value	-10.77	-7.97	-7.3
Machinery	9.06	9.02	7.55
Construction In Progress	4.09	3.59	-
Leasehold Improvements	0.8	0.44	0.44

Source: S&P Capital IQ. Standard template.